Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 27, 2022
Identifying health-related quality of life cut-off scores that indicate the need for supportive care in young adults with cancerEmma Lidington, Johannes M Giesinger, Silvie H M Janssen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 18, 2020
The FOCCUS study: a prospective evaluation of the frequency, severity and treatable causes of gastrointestinal symptoms during and after chemotherapyH Jervoise N Andreyev, Amyn Lalji, Kabir Mohammed, et al.
Future Oncology (London, England)|January 6, 2026
A Phase III study of perioperative dostarlimab in patients with dMMR/MSI-H resectable colon cancer: AZUR-2 study designNaureen Starling, Elena Elez, John H Strickler, et al.
Frontiers in Oncology|December 14, 2023
MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patientsHazel Lote, Florentia Mousoullou, George Vlachogiannis, et al.
The Lancet. Gastroenterology & Hepatology|May 19, 2026
Management of colorectal cancer in older adults: an expert panel recommendation to guide daily clinical practiceGabor Liposits, Thierry André, Thomas Aparicio, et al.
ESMO Open|February 22, 2020
Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised studyDavid Lau, Eleftheria Kalaitzaki, David N Church, et al.
Cancers|May 30, 2019
Detecting and Tracking Circulating Tumour DNA Copy Number Profiles during First Line Chemotherapy in Oesophagogastric AdenocarcinomaMichael Davidson, Louise J Barber, Andrew Woolston, et al.
Journal of the National Cancer Institute|April 24, 2020
Computational Image Analysis of T-Cell Infiltrates in Resectable Gastric Cancer: Association with Survival and Molecular SubtypesBenjamin R Challoner, Katharina von Loga, Andrew Woolston, et al.
BMC Cancer|March 21, 2023
ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C)Susanna Slater, Annette Bryant, Hsiang-Chi Chen, et al.
BMC Cancer|April 26, 2023
Impact of pharmacogenomic DPYD variant guided dosing on toxicity in patients receiving fluoropyrimidines for gastrointestinal cancers in a high-volume tertiary centreDavid K Lau, Caroline Fong, Faten Arouri, et al.
Pageof 13